These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2612516)

  • 1. Mephenytoin stereoselective elimination in the rat: I. Enantiomeric disposition following intravenous administration.
    Akrawi SH; Wedlund PJ
    Eur J Drug Metab Pharmacokinet; 1989; 14(3):195-200. PubMed ID: 2612516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mephenytoin stereoselective elimination in the rat: II. Comparison of mephenytoin stereoselective clearance during chronic intravenous and hepatic portal vein administration.
    Akrawi SH; Wedlund PJ
    Eur J Drug Metab Pharmacokinet; 1989; 14(4):269-78. PubMed ID: 2633921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mephenytoin stereoselective elimination in the rat: III. Stereoselective time course of induction during chronic hepatic portal vein administration.
    Akrawi SH; Wedlund PJ
    Eur J Drug Metab Pharmacokinet; 1990; 15(3):245-51. PubMed ID: 2253655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective metabolism and disposition of the enantiomers of mephenytoin during chronic oral administration of the racemic drug in man.
    Küpfer A; Desmond PV; Schenker S; Branch RA
    J Pharmacol Exp Ther; 1982 Jun; 221(3):590-7. PubMed ID: 7086673
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenotypic differences in mephenytoin pharmacokinetics in normal subjects.
    Wedlund PJ; Aslanian WS; Jacqz E; McAllister CB; Branch RA; Wilkinson GR
    J Pharmacol Exp Ther; 1985 Sep; 234(3):662-9. PubMed ID: 4032286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct enantiomeric resolution of mephenytoin and its N-demethylated metabolite in plasma and blood using chiral capillary gas chromatography.
    Wedlund PJ; Sweetman BJ; McAllister CB; Branch RA; Wilkinson GR
    J Chromatogr; 1984 Apr; 307(1):121-7. PubMed ID: 6725478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor, in extensive and poor metabolizers of S-mephenytoin.
    Tanaka M; Ohkubo T; Otani K; Suzuki A; Kaneko S; Sugawara K; Ryokawa Y; Ishizaki T
    Clin Pharmacol Ther; 2001 Mar; 69(3):108-13. PubMed ID: 11240974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Method for chronic portal vein infusion in unrestrained rats.
    Akrawi SH; Wedlund PJ
    J Pharmacol Methods; 1987 Mar; 17(1):67-74. PubMed ID: 3560987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylation.
    Küpfer A; Branch RA
    Clin Pharmacol Ther; 1985 Oct; 38(4):414-8. PubMed ID: 4042524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mephenytoin disposition and serum bile acids as indices of hepatic function in chronic viral hepatitis.
    Arns PA; Adedoyin A; DiBisceglie AM; Waggoner JG; Hoofnagle JH; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1997 Nov; 62(5):527-37. PubMed ID: 9390109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective differences in propranolol disposition in female Sprague-Dawley and Dark Agouti rats.
    Guttendorf RJ; Kostenbauder HB; Wedlund PJ
    Drug Metab Dispos; 1991; 19(1):251-6. PubMed ID: 1673410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic disposition of lansoprazole in relation to the S-mephenytoin 4'-hydroxylation phenotype status.
    Sohn DR; Kwon JT; Kim HK; Ishizaki T
    Clin Pharmacol Ther; 1997 May; 61(5):574-82. PubMed ID: 9164419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselectivity of the arene epoxide pathway of mephenytoin hydroxylation in man.
    Küpfer A; Lawson J; Branch RA
    Epilepsia; 1984 Feb; 25(1):1-7. PubMed ID: 6420144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition kinetics of d- and l-amphetamine following intravenous administration of racemic amphetamine to rats.
    Hutchaleelaha A; Sukbuntherng J; Chow HH; Mayersohn M
    Drug Metab Dispos; 1994; 22(3):406-11. PubMed ID: 8070317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humans.
    Küpfer A; Patwardhan R; Ward S; Schenker S; Preisig R; Branch RA
    J Pharmacol Exp Ther; 1984 Jul; 230(1):28-33. PubMed ID: 6747829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mephenytoin hydroxylation deficiency: kinetics after repeated doses.
    Küpfer A; Desmond P; Patwardhan R; Schenker S; Branch RA
    Clin Pharmacol Ther; 1984 Jan; 35(1):33-9. PubMed ID: 6690169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species differences in stereoselective metabolism of mephenytoin by cytochrome P450 (CYP2C and CYP3A).
    Yasumori T; Chen L; Nagata K; Yamazoe Y; Kato R
    J Pharmacol Exp Ther; 1993 Jan; 264(1):89-94. PubMed ID: 8423554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans.
    Fritz S; Lindner W; Roots I; Frey BM; Küpfer A
    J Pharmacol Exp Ther; 1987 May; 241(2):615-22. PubMed ID: 3572817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the pharmacokinetics and pharmacodynamics of the aldose reductase inhibitors, AL03152 (RS), AL03802 (R), and AL03803 (S).
    Park YH; Mayer PR; Barker R; DuPriest M; Griffin BW; Williams GW; York BM; Slattery JT
    Pharm Res; 1993 Apr; 10(4):593-7. PubMed ID: 8483844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The optical resolution of racemic chlorpheniramine and its stereoselective pharmacokinetics in rat plasma.
    Sakurai E; Yamasaki S; Iizuka Y; Hikichi N; Niwa H
    J Pharm Pharmacol; 1992 Jan; 44(1):44-7. PubMed ID: 1350627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.